The Law Offices of Frank R. Cruz Announces Investigation of Ventyx Biosciences, Inc. (VTYX) on Behalf of InvestorsBusiness Wire • 03/06/24
Shareholders that lost money on Ventyx Biosciences, Inc. (VTYX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 03/06/24
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYXPRNewsWire • 03/05/24
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Ventyx Biosciences, Inc. (VTYX) InvestorsBusiness Wire • 03/04/24
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses In Excess of $100,000 to Contact the FirmAccesswire • 03/04/24
ROSEN, A LEADING LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – VTYXBusiness Wire • 03/03/24
Ventyx Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Corporate ProgressGlobeNewsWire • 02/27/24
Ventyx Biosciences to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceGlobeNewsWire • 02/06/24
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 01/12/24
IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 01/09/24
Ventyx Biosciences to Participate in the 35th Annual Piper Sandler Healthcare ConferenceGlobeNewsWire • 11/21/23
VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of Ventyx Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 11/11/23
Ventyx Biosciences to Participate in the Jefferies London Healthcare ConferenceGlobeNewsWire • 11/10/23
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 11/10/23
Ventyx Biosciences Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate ProgressGlobeNewsWire • 11/09/23
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Ventyx Biosciences, Inc. (VTYX)Business Wire • 11/09/23
Down -86.57% in 4 Weeks, Here's Why Ventyx Biosciences, Inc. (VTYX) Looks Ripe for a TurnaroundZacks Investment Research • 11/09/23
Ventyx Crashes 82% After Scrapping Two Studies On A Psoriasis Treatment FlopInvestors Business Daily • 11/07/23
Ventyx Biosciences' stock suffering record plunge after psoriasis treatment trial fails to meet internal efficacy targetMarket Watch • 11/07/23
Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958 in Patients with Moderate to Severe Plaque Psoriasis and Provides Corporate UpdateGlobeNewsWire • 11/06/23
Ventyx (VTYX) Down Despite Positive Ulcerative Colitis Study DataZacks Investment Research • 10/11/23